Bristol-Myers Squibb Co. (BMY) Discloses Financial and Operational Insights Within Their Latest Quarterly Report
The pharmaceutical company's financials show steady revenue growth and improved net income margin in 2024. Management focuses on diversifying the portfolio, advancing drug development, and mitigating risks. Key performance indicators...









